During the past decade, National Research Center for Radiation Medicine conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 2 clinical trials were completed, i.e. on average, 18.2% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "National Research Center for Radiation Medicine" #1 sponsor was "AOP Orphan Pharmaceuticals AG" with 3 trials, followed by "National Cancer Institute (NCI)" with 3 trials sponsored, "Celgene" with 2 trials sponsored, "Takeda" with 2 trials sponsored and "Actelion" with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "National Research Center for Radiation Medicine" #1 collaborator was "Brigham and Women's Hospital" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "PharmaEssentia (Co-Sponsor for USA)" with 1 trials as a collaborator, "PharmaEssentia Corporation (Co-Sponsor for USA)" with 1 trials as a collaborator and "PharmaEssentia Corporation (for the U.S.)" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "National Research Center for Radiation Medicine" are "Multiple Sclerosis" (3 trials), "Polycythemia Vera" (3 trials), "B-cell Non-Hodgkin's Lymphoma" (1 trials), "Colitis, Ulcerative" (1 trials) and "Crohn's Disease (CD)" (1 trials). Many other conditions were trialed in "National Research Center for Radiation Medicine" in a lesser frequency.

Most popular intervention types in "National Research Center for Radiation Medicine" are "Drug" (11 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Best available therapy (BAT)" (1 trials), "Debio 1562" (1 trials), "Hydroxyurea" (1 trials) and "Interferon beta-1a" (1 trials). Other intervention names were less common.

The vast majority of trials in "National Research Center for Radiation Medicine" are 14 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "National Research Center for Radiation Medicine". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in National Research Center for Radiation Medicine, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in National Research Center for Radiation Medicine, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".